Kuldeep S. Attri

1.9k citations
16 papers · 592 indexed · h-index 11
Topics
Cancer, Hypoxia, and Metabolism (5 papers)Immune cells in cancer (4 papers)Glycosylation and Glycoproteins Research (2 papers)
Partner nations
United StatesChinaIndia

In The Last Decade

Kuldeep S. Attri

15 papers receiving 583 citations

Peers

Kuldeep S. Attri
Comparison fields: 5 of 84
  • Molecular Biology 393
  • Immunology 244
  • Oncology 111
  • Cancer Research 90
  • Physiology 84
Replace Leal Oburoglu with:
Leal Oburoglu Sweden
Osman Çen United States
Jana Dobrovolná Czechia
Jin Qian China
Zbigniew Korwek Poland
Xudong Li China
Zengli Guo United States
Bojana Müller-Durovic Switzerland
Mark Tsang United States
Shen‐Wu Wang China
Kuldeep S. Attri relative to Leal Oburoglu Sweden Leal Oburoglu's profile →
Citations per field
00.5×1.5×
Leal Oburoglu · 1×
Citations per year

Countries citing papers authored by Kuldeep S. Attri

Since Specialization
Citations

This map shows the geographic impact of Kuldeep S. Attri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuldeep S. Attri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuldeep S. Attri more than expected).

Fields of papers citing papers by Kuldeep S. Attri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuldeep S. Attri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuldeep S. Attri. The network helps show where Kuldeep S. Attri may publish in the future.

Co-authorship network of co-authors of Kuldeep S. Attri

This figure shows the co-authorship network connecting the top 25 collaborators of Kuldeep S. Attri. A scholar is included among the top collaborators of Kuldeep S. Attri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuldeep S. Attri. Kuldeep S. Attri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 15
2 21
3 1
4 32
5 6
6 0
7 13
8 64
9 37
10 50
11 146
12 106
13 20
14 66
15 7
16 8

About Kuldeep S. Attri

Kuldeep S. Attri is a scholar working on Cancer Research, Immunology and Virology, having authored 16 papers that have together received 592 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (4 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (244 citations), Cancer Research (90 citations) and Molecular Biology (393 citations). Kuldeep S. Attri has collaborated with scholars based in United States, China and India. Frequent co-authors include Pankaj K. Singh, Divya Murthy, Laura E. Herring, Yu L. Lei, John M. Asara, Tianliang Li, Haitao Wen, Surendra K. Shukla, Kamiya Mehla and Ryan J. King. Their work appears in journals such as Proceedings of the National Academy of Sciences, Immunity and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026